Universal Health Services debt and dilution53

Borrowings, liquidity, share count and stock-based dilution.

Total debt

USD millions

$4,851.847M

Cash & equivalents

USD millions

$138.8M

Net debt

USD millions

$4,713.047M

Debt / equity

0.64×

Debt / assets

30.45%

Net debt / EBITDA

× · TTM

1.75×

Debt / FCF

× · TTM

5.74×

Interest coverage

× · TTM

13.05×

Current ratio

1.12×

Diluted shares

Million shares

59.91M shares

Basic shares

Million shares

59.66M shares

Share count growth

-7.3%

Share repurchases

USD millions

$320.752M

Quarterly data

Universal Health Services capital history. Each metric has its own unit. A dash means inputs are missing or the calculation is undefined.
Fiscal period	Ended	Total debtUSD millions	Cash & equivalentsUSD millions	Net debtUSD millions	Debt / equity×	Debt / assets%	Net debt / EBITDA×	Debt / FCF×	Interest coverage×	Current ratio×	Diluted sharesMillion shares	Basic sharesMillion shares	Share count growth%	Share repurchasesUSD millions
FY 2026 Q2	Jun 30, 2026	4,851.85	138.8	4,713.05	0.64×	30.45%	1.75×	5.74×	13.05×	1.12×	59.91	59.66	-7.3%	320.75
FY 2026 Q1	Mar 31, 2026	4,708.36	119.03	4,589.33	0.63×	30.03%	1.72×	5.16×	13.33×	1.08×	61.67	61.07	-6%	163.85
FY 2025 Q4	Dec 31, 2025	4,752.55	137.8	4,614.75	0.65×	30.61%	1.77×	5.6×	12.78×	1.05×	63.17	62.04	-5.43%	352.01
FY 2025 Q3	Sep 30, 2025	4,691.12	112.9	4,578.22	0.65×	30.57%	1.79×	4.84×	12.69×	1.03×	63.66	62.97	-5.35%	237.4
FY 2025 Q2	Jun 30, 2025	4,582.9	137.6	4,445.3	0.65×	30.58%	1.85×	5.08×	11.34×	1.29×	64.99	64.36	-3.77%	155.16
FY 2025 Q1	Mar 31, 2025	4,649.68	126.75	4,522.93	0.68×	31.26%	1.93×	4.4×	10.08×	1.32×	66.04	64.97	-3.32%	223.39
FY 2024 Q4	Dec 31, 2024	4,504.54	125.98	4,378.56	0.67×	31.13%	1.93×	4.01×	9.04×	1.27×	67.08	65.6	-3.28%	250.17
FY 2024 Q3	Sep 30, 2024	4,656.41	106.08	4,550.33	0.7×	32.44%	2.14×	4.87×	7.7×	1.39×	68.11	66.54	-3.38%	182.6
FY 2024 Q2	Jun 30, 2024	4,544.24	128.79	4,415.45	0.69×	32.29%	2.19×	5.45×	6.91×	1.28×	67.92	66.88	-4.56%	95.9
FY 2024 Q1	Mar 31, 2024	4,861.81	112.09	4,749.71	0.77×	34.61%	2.56×	8.23×	6.16×	1.38×	68.48	67.2	-4.72%	142.08
FY 2023 Q4	Dec 31, 2023	4,912.47	119.44	4,793.03	0.79×	35.17%	2.75×	9.36×	5.69×	1.4×	68.57	67.83	-4.72%	162.02
FY 2023 Q3	Sep 30, 2023	4,922.63	80.77	4,841.86	0.81×	35.48%	2.89×	11.96×	5.61×	1.38×	69.62	68.87	-5.14%	175.58
FY 2023 Q2	Jun 30, 2023	4,716.43	79.45	4,636.98	0.77×	34.35%	2.77×	9.27×	6.11×	1.29×	70.84	70.07	-4.9%	124.72
FY 2023 Q1	Mar 31, 2023	4,803.56	109.97	4,693.59	0.79×	35.44%	2.88×	34.66×	6.72×	1.37×	71.49	70.54	-5.99%	85.04
FY 2022 Q4	Dec 31, 2022	4,807.98	102.82	4,705.16	0.81×	35.63%	2.97×	18.35×	7.91×	1.33×	71.81	71.19	-9.72%	109.53
FY 2022 Q3	Sep 30, 2022	4,704.66	74.57	4,630.09	0.8×	35.16%	2.85×	17.99×	10.33×	1.27×	73.06	72.6	-11.75%	158.2
FY 2022 Q2	Jun 30, 2022	4,665.41	132.66	4,532.75	0.79×	35.09%	2.75×	10.12×	12.47×	1.22×	74.44	73.68	-12.52%	199.68
FY 2022 Q1	Mar 31, 2022	4,299.18	106	4,193.18	0.72×	32.71%	2.27×	9.57×	15.59×	1.07×	76.04	75.03	-11.5%	365.51
FY 2021 Q4	Dec 31, 2021	4,190.29	115.3	4,074.99	0.68×	32%	2.15×	149.46×	16.29×	1.14×	79.72	78.85	-6.94%	450.21
FY 2021 Q3	Sep 30, 2021	3,754.28	189.74	3,564.53	0.59×	29.22%	1.78×	—	17.35×	1.19×	83.67	82.26	-2.85%	402.59
FY 2021 Q2	Jun 30, 2021	3,593.59	199.02	3,394.58	0.55×	28.05%	1.68×	21.22×	17.08×	1.2×	85.62	84.22	-0.48%	360.62
FY 2021 Q1	Mar 31, 2021	3,613.1	764.5	2,848.6	0.55×	27.59%	1.47×	3.18×	15.42×	1.24×	85.8	84.78	-1.66%	7.46
FY 2020 Q4	Dec 31, 2020	3,856.25	1,224.49	2,631.76	0.6×	28.61%	1.41×	2.37×	12.78×	1.32×	85.59	84.73	-2.83%	6.62
FY 2020 Q3	Sep 30, 2020	3,609.18	1,101.23	2,507.95	0.6×	27.81%	1.4×	1.89×	10.24×	1.12×	85.25	84.67	-3.73%	0.04
FY 2020 Q2	Jun 30, 2020	3,532.03	539.62	2,992.4	0.61×	29.07%	1.84×	2.21×	7.9×	1.02×	85.06	84.63	-5.05%	27.96
FY 2020 Q1	Mar 31, 2020	3,805.32	54.62	3,750.7	0.69×	32.75%	2.33×	4.22×	6.98×	1.09×	86.46	86.21	-5.03%	172.09
FY 2019 Q4	Dec 31, 2019	3,984.13	61.27	3,922.86	0.71×	34.15%	2.3×	4.95×	7.47×	1.23×	87.62	87.2	-5.42%	182.53
FY 2019 Q3	Sep 30, 2019	3,948.37	58.91	3,889.47	0.72×	34.05%	2.41×	4.99×	6.94×	1.19×	88.36	87.95	-5.27%	93.33
FY 2019 Q2	Jun 30, 2019	4,148.95	61.3	4,087.66	0.76×	35.3%	2.44×	5.79×	7.45×	1.27×	89.24	89.14	-5.01%	350.86
FY 2019 Q1	Mar 31, 2019	3,893.93	62.73	3,831.2	0.7×	33.22%	2.33×	5.39×	7.53×	1.18×	90.97	90.78	-3.66%	143.79
FY 2018 Q4	Dec 31, 2018	3,998.63	105.22	3,893.41	0.73×	35.49%	2.39×	5.92×	7.58×	1.34×	92.72	92.2	-2.48%	136.17
FY 2018 Q3	Sep 30, 2018	4,026.34	83.72	3,942.62	0.74×	35.71%	2.32×	6.5×	8.26×	1.09×	93.33	92.85	-2.52%	126.47
FY 2018 Q2	Jun 30, 2018	3,990.46	76.89	3,913.58	0.74×	36.05%	2.3×	6.51×	8.4×	1.3×	94.28	93.84	-2.5%	125.34
FY 2018 Q1	Mar 31, 2018	3,921.34	73.05	3,848.28	0.74×	35.57%	2.25×	8.5×	8.56×	1.19×	94.68	94.23	-2.44%	9.44
FY 2017 Q4	Dec 31, 2017	4,040.01	74.42	3,965.59	0.8×	37.54%	2.29×	6.46×	8.82×	0.97×	94.92	94.54	-2.53%	121.53
FY 2017 Q3	Sep 30, 2017	4,040.15	65.42	3,974.73	0.82×	37.97%	2.34×	7.71×	8.89×	1.26×	95.98	95.25	-1.93%	95.41
FY 2017 Q2	Jun 30, 2017	4,115.02	66.45	4,048.58	0.84×	39%	2.37×	8.46×	9.35×	1.33×	97.04	96.25	-0.89%	118.3
FY 2017 Q1	Mar 31, 2017	3,898.58	62.97	3,835.6	0.81×	37.31%	2.25×	5.06×	9.77×	1.14×	97.37	96.59	-1.05%	29.17
FY 2016 Q4	Dec 31, 2016	4,136.13	33.75	4,102.38	0.9×	40.09%	2.42×	5.38×	10.25×	1.28×	97.92	97	-1.44%	56.2
FY 2016 Q3	Sep 30, 2016	3,634.17	61.74	3,572.42	0.81×	37.57%	2.1×	4.44×	10.67×	1.24×	98.32	97.12	-1.76%	58.04
FY 2016 Q2	Jun 30, 2016	3,594.18	56.27	3,537.9	0.82×	37.67%	2.09×	4.31×	11.11×	1.27×	98.39	97.11	-1.91%	68.1
FY 2016 Q1	Mar 31, 2016	3,280.41	54.59	3,225.82	0.75×	34.3%	1.91×	4.12×	11.4×	0.97×	98.9	97.61	-1.32%	171.04
FY 2015 Q4	Dec 31, 2015	3,450.03	61.23	3,388.8	0.8×	35.81%	2.04×	5.38×	11.1×	1.56×	100.05	98.42	-0.39%	79.92
FY 2015 Q3	Sep 30, 2015	3,094.84	39.52	3,055.31	0.74×	33.61%	1.85×	3.91×	10.85×	1.42×	101.16	98.86	-0.2%	61.71
FY 2015 Q2	Jun 30, 2015	3,035.32	42.46	2,992.86	0.74×	33.43%	1.93×	4.13×	9.59×	1.43×	100.93	99	0.13%	39.39
FY 2015 Q1	Mar 31, 2015	3,140.59	35.08	3,105.52	0.79×	34.57%	2.07×	4.34×	8.71×	1.37×	100.65	98.91	0.34%	28.77
FY 2014 Q4	Dec 31, 2014	88.84	32.07	56.77	0.02×	0.99%	0.04×	0.14×	7.96×	1.37×	100.75	98.81	0.58%	37.46
FY 2014 Q3	Sep 30, 2014	3,454.82	39.71	3,415.11	0.94×	38.55%	2.53×	5.82×	7.12×	1.39×	101.03	99.05	0.92%	27.52
FY 2014 Q2	Jun 30, 2014	3,148	14.73	3,133.27	0.87×	36.83%	2.25×	5.55×	7.46×	1.37×	100.24	98.87	0.86%	21.78
FY 2014 Q1	Mar 31, 2014	3,212.8	16.26	3,196.54	0.93×	38.11%	2.29×	5.99×	7.37×	1.39×	100.16	98.57	0.88%	13.99
FY 2013 Q4	Dec 31, 2013	105.17	17.24	87.93	0.03×	1.27%	0.06×	0.2×	6.95×	1.35×	100.07	98.23	-74.48%	5.02
FY 2013 Q3	Sep 30, 2013	3,499.93	12.12	3,487.81	1.11×	41.91%	2.53×	6.85×	6.91×	1.47×	99.59	98.15	101,277.86%	0.81
FY 2013 Q2	Jun 30, 2013	3,546.69	12.56	3,534.13	1.17×	42.64%	2.69×	7.21×	6.03×	1.41×	99.21	98.03	1.39%	7.35
FY 2013 Q1	Mar 31, 2013	3,670.47	17.4	3,653.08	1.27×	44.13%	2.96×	7.21×	5.33×	1.56×	98.57	97.71	1.16%	14.03
FY 2012 Q4	Dec 31, 2012	9.27	23.47	-14.2	0×	0.11%	-0.01×	0.02×	5.27×	1.57×	388.43	384.89	—	9.48
FY 2012 Q3	Sep 30, 2012	3,443.46	25.65	3,417.81	1.29×	44.25%	—	—	—	1.78×	0.1	0.1	—	6.75
FY 2012 Q2	Jun 30, 2012	3,461.01	32.94	3,428.07	1.34×	44.61%	—	—	—	1.65×	97.73	96.69	—	0.91
FY 2012 Q1	Mar 31, 2012	3,584.36	42	3,542.36	1.45×	46.05%	—	—	—	1.64×	97.79	96.59	—	2.02

Sources and calculations

Financial inputs from company filings. Last checked Oct 18, 2026. A dash means missing inputs or an undefined calculation.

Period changes use the preceding fiscal quarter or year. Percentage changes divide by the absolute prior value; a zero or missing baseline has no percentage change. Percentage metrics show changes in percentage points.

The SBC option subtracts reported share-based compensation from FCF as an economic-cost scenario. Missing SBC never becomes zero.

Debt uses reported borrowings, with overlapping concepts treated as alternatives. Cash excludes restricted cash and short-term investments. Dilution compares split-normalized weighted average basic shares year over year. Share buyback spending does not by itself measure shares retired.

Market prices: Yahoo Finance · UHS, USD. Latest completed close Sep 25, 2026. Price data retrieved Sep 28, 2026.

Total debt: Reported borrowing balances. Uses an aggregate including current maturities, or current plus noncurrent debt. Adds separately disclosed short-term borrowings, with commercial paper as a fallback, unless the selected current/aggregate concept already includes them. Finance leases are included when part of the reported debt concept; undisclosed components are not estimated.
Cash & equivalents: Unrestricted reported cash and cash equivalents. Excludes short-term investments and restricted cash.
Net debt: Total debt − cash and equivalents. Negative means net cash.
Debt / equity: Total debt / equity including noncontrolling interests. Nonpositive equity yields unavailable.
Debt / assets: Total debt / total assets × 100.
Net debt / EBITDA: Period-end net debt / (TTM operating income + TTM depreciation and amortization). Negative net debt is retained.
Debt / FCF: Period-end reported debt / positive TTM free cash flow. Reflects the selected reported capex scope and SBC option.
Interest coverage: TTM operating income / positive TTM interest expense. IFRS finance costs can include more than interest.
Current ratio: Current assets / positive current liabilities.
Diluted shares: Reported weighted average diluted shares, normalized for subsequent recorded stock splits. Fourth-quarter counts use a day-weighted annual/nine-month reconstruction where possible.
Basic shares: Reported weighted average basic shares, normalized for subsequent recorded stock splits.
Share count growth: Year-over-year change in split-normalized weighted average basic shares × 100. A dilution proxy; negative means a lower share count.
Share repurchases: Reported cash payments for repurchase of common shares. This is spending, not a buyback yield.

SEC company facts · CIK 352915